Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US - Concepedia

Concepedia

Publication | Closed Access

Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US

78

Citations

32

References

2013

Year

Anju Parthan, Morgan Kruse, Nicole Yurgin, Joice Huang, Hema N. Viswanathan, Douglas C.A. Taylor

Applied Health Economics and Health Policy

Bone DiseaseBone HealthHealth EconomicsPostmenopausal OsteoporosisOutcomes ResearchOrthopaedicsOsteoporosisCost EffectivenessOral BisphosphonatesMedicineOrthopaedic Surgery

References

	Year	Citations

Page 1